Oral Nutrition Supplements for Cancer Patients: What to Use and When

Oral nutrition supplements (ONS) are one of the most commonly recommended nutrition interventions in oncology — and one of the most inconsistently applied. Patients are frequently told to "drink Ensure" without any guidance on which product, how much, when, or whether it's even the right tool for their situation. Many end up buying the wrong formula, using it incorrectly, or abandoning it because it's intolerable with their current side effects.

This post cuts through the brand confusion, explains when ONS actually help (and when they don't), and gives you a practical framework for choosing and using them effectively.

What ONS Are — and What They're Not

Oral nutrition supplements are commercially formulated, nutritionally complete or semi-complete liquid or semi-solid products designed to supplement — or in some cases replace — food intake. They range from standard meal-replacement drinks to highly specialized formulas for specific disease states or metabolic needs.

They are not the same as protein powders sold in supplement stores (which are typically not nutritionally complete and vary widely in quality), and they are not interchangeable with each other. Choosing a formula based on what's on sale at the grocery store is the nutritional equivalent of choosing a medication based on what's cheapest at the pharmacy — the active ingredients and intended uses are different.

When ONS Are Indicated in Cancer Patients

Not every cancer patient needs an oral supplement. ONS are most appropriate when:

• Food intake is consistently below estimated needs by more than 25–30% for more than a few days
• Unintentional weight loss of >2% over 1 month or >5% over 6 months is occurring despite attempts to eat adequately
• Treatment side effects (nausea, mucositis, dysphagia, fatigue) are making solid food intake consistently difficult
• Protein needs are elevated (post-surgery, cachexia, corticosteroid use) and dietary sources alone are insufficient
• Specific medical nutrition needs exist that can't be met through food modification alone (malabsorption, fluid restriction, organ dysfunction)

If a patient is eating well, maintaining weight, and tolerating food, pushing ONS is unnecessary and can actually displace more nutritionally complex food from the diet. The goal is always food first — ONS fill the gap when food can't.

Understanding the Product Categories

Standard polymeric formulas

The Ensure Original, Boost Original tier. Whole protein, standard macronutrient ratios, 200–250 kcal per 8 oz serving, 8–10g protein. Appropriate for patients with a functioning GI tract who need caloric supplementation without specific medical needs. Widely available but relatively low in protein density — not the best choice when protein is the primary goal.

High-calorie / high-protein formulas

Ensure Plus, Boost High Protein, Boost Plus, Ensure High Protein — deliver more calories (350–360 kcal/8oz) and/or more protein (15–20g per serving) in the same or smaller volume. Better suited to patients with appetite suppression who need to maximize nutrition per sip. When food intake is very low, volume is the limiting factor — calorie density matters.

Specialized oncology formulas

Products specifically formulated for cancer or cachexia patients — typically containing EPA (omega-3), HMB (β-hydroxy β-methylbutyrate), higher protein, and anti-inflammatory fatty acid profiles. Examples include Ensure Surgery (formerly Ensure Pre-Surgery), ProSure (Abbott, available in some markets), and Meritene Strength. These have more specific evidence for lean mass preservation in cachectic patients than standard formulas.

Semi-elemental and elemental formulas

Peptamen, Vital, Tolerex — proteins are pre-digested into peptides or free amino acids, fats are partially or fully replaced with medium-chain triglycerides (MCTs). Appropriate when GI function is compromised — Whipple surgery, short bowel syndrome, radiation enteritis, severe pancreatic insufficiency, severe malabsorption. Not appropriate as a first-line choice in patients with normal GI function; significantly more expensive and less palatable.

Disease-specific formulas

Diabetic formulas (Glucerna, Boost Glucose Control) — lower glycemic index, modified carbohydrate profile. Appropriate for patients with steroid-induced hyperglycemia or concurrent diabetes. Renal formulas (Nepro, Suplena) — fluid, phosphorus, potassium, and sodium restricted. For patients with concurrent renal insufficiency. Hepatic formulas — branched-chain amino acid enriched for patients with hepatic encephalopathy.

Oral protein supplements / powders

Unflavored whey protein isolate (e.g., Unjury, Isopure Unflavored, ProSource No-Carb), collagen peptides, plant-based protein powders. Not nutritionally complete — calorie, vitamin, and mineral content is minimal or absent. Used to boost protein intake in specific meals, smoothies, or soft foods when protein is the limiting nutrient and calorie needs are being met through food. Useful, but not an ONS substitute.

Product Comparison: Common ONS in Oncology Practice

Matching the Formula to the Clinical Situation

Palatability: The Biggest Real-World Problem

The best formula is the one the patient will actually drink. Palatability fatigue — gradually finding a supplement increasingly intolerable — is the most common reason ONS fail in practice. Strategies to extend palatability:

• Rotate flavors and brands. Drinking the same vanilla shake twice a day for six weeks will predictably end in aversion. Variety across flavors, textures, and brands reduces flavor fatigue.
• Serve cold. Almost all liquid ONS are more tolerable cold than at room temperature. Keep refrigerated; serve over ice if needed.
• Use in recipes. ONS can be blended into smoothies, used as a milk substitute in oatmeal or pudding, or mixed into yogurt. This disguises the flavor and adds food-based variety.
• Small volumes more frequently. A 4 oz serving four times per day is often more tolerable than 8 oz twice. The stomach empties small volumes faster and appetite suppression is less pronounced.
• Don't drink with or immediately before meals. ONS taken with meals suppress appetite for the meal itself. Use between meals — mid-morning and mid-afternoon — as true supplementation, not meal replacement.
• Experiment with semi-solid formats. Pudding-format ONS (Ensure Pudding, Boost Pudding) are significantly better tolerated by some patients, particularly those with nausea triggered by liquid volume or patients who have difficulty swallowing thin liquids.

Building a High-Calorie, High-Protein Smoothie From Scratch

For patients who can tolerate smoothies, a well-constructed homemade version often delivers better nutrition, better palatability, and lower cost than commercial ONS — particularly when combined with unflavored protein powder. Here's the framework:

Insurance Coverage and Cost

ONS cost can be a real barrier — specialty formulas especially. A few things worth knowing:

• Medicare Part B covers enteral nutrition (tube feeding) but generally does not cover oral supplements, even when medically necessary. This is a well-known gap in oncology nutrition care.
• Some Medicare Advantage, Medicaid, and private insurance plans do cover ONS with a medical necessity letter from a physician or dietitian. It's always worth checking before assuming there's no coverage.
• Manufacturer patient assistance programs exist for specialty formulas (Abbott, Nestlé Health Science). Patients who cannot afford specialized oncology formulas should ask their dietitian or social worker about these programs.
• Buying in bulk at warehouse stores (Costco, Sam's Club) significantly reduces per-serving cost for standard formulas. Amazon Subscribe & Save is another cost-reduction option for patients on ongoing supplementation.
• Generic store-brand equivalents of standard polymeric formulas (Walgreens, CVS, Walmart) are nutritionally equivalent to Ensure/Boost at meaningfully lower cost. They're a reasonable option for standard-tier supplementation.